Natera partners with CytoDyn for colorectal cancer drug development
Go back to Natera partners with CytoDyn for colorectal cancer drug development| CytoDyn, Inc. (AMEX: CYDY) | Delayed: 0.26 -0.01 (3.7%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.27 | 52 Week High | $1.57 | |||
| Open | $0.27 | 52 Week Low | $0.61 | |||
| Day High | $0.27 | P/E | N/A | |||
| Day Low | $0.26 | EPS | $0.00 | |||
| Volume | 1,684,863 | |||||
| (NASDAQ: NTRA) | Delayed: 228.80 -2.61 (1.13%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $231.41 | 52 Week High | $13.80 | |||
| Open | $231.52 | 52 Week Low | $6.52 | |||
| Day High | $234.14 | P/E | N/A | |||
| Day Low | $219.50 | EPS | $0.00 | |||
| Volume | 1,577,833 | |||||
